Center for Genomic Regulation (CRG)-Universitat Pompeu Fabra (UPF), Barcelona, Spain.
BMC Genomics. 2011 Jun 23;12:326. doi: 10.1186/1471-2164-12-326.
Epidermal Growth Factor (EGF) is a key regulatory growth factor activating many processes relevant to normal development and disease, affecting cell proliferation and survival. Here we use a combined approach to study the EGF dependent transcriptome of HeLa cells by using multiple long oligonucleotide based microarray platforms (from Agilent, Operon, and Illumina) in combination with digital gene expression profiling (DGE) with the Illumina Genome Analyzer.
By applying a procedure for cross-platform data meta-analysis based on RankProd and GlobalAncova tests, we establish a well validated gene set with transcript levels altered after EGF treatment. We use this robust gene list to build higher order networks of gene interaction by interconnecting associated networks, supporting and extending the important role of the EGF signaling pathway in cancer. In addition, we find an entirely new set of genes previously unrelated to the currently accepted EGF associated cellular functions.
We propose that the use of global genomic cross-validation derived from high content technologies (microarrays or deep sequencing) can be used to generate more reliable datasets. This approach should help to improve the confidence of downstream in silico functional inference analyses based on high content data.
表皮生长因子(EGF)是一种关键的调节生长因子,激活许多与正常发育和疾病相关的过程,影响细胞增殖和存活。在这里,我们使用了一种联合方法,通过使用多个基于长寡核苷酸的微阵列平台(来自 Agilent、Operon 和 Illumina)以及与 Illumina 基因组分析仪相结合的数字基因表达谱(DGE)来研究 HeLa 细胞中 EGF 依赖性转录组。
通过应用基于 RankProd 和 GlobalAncova 检验的跨平台数据荟萃分析程序,我们建立了一个经过充分验证的基因集,其中转录水平在 EGF 处理后发生了改变。我们使用这个稳健的基因列表通过相互连接相关网络构建基因相互作用的高阶网络,支持和扩展了 EGF 信号通路在癌症中的重要作用。此外,我们发现了一组全新的基因,它们以前与目前公认的 EGF 相关的细胞功能无关。
我们提出,使用源自高通量技术(微阵列或深度测序)的全局基因组交叉验证可以生成更可靠的数据集。这种方法应该有助于提高基于高通量数据的下游计算功能推断分析的置信度。